All Posts
Cholangiocarcinoma Foundation Awards $365k in Research Fellowship Grants in Largest Funding Cycle to Date
Since 2015, the Foundation has awarded more than $1.9 million in funding for innovative, high-quality research. SALT LAKE CITY, UTAH,…
Cholangiocarcinoma Foundation Awards $365k in Research Fellowship Grants in Largest Funding Cycle to Date
Read the full article by clicking here.
The Cancerbet – or What Cancer Does and Does NOT do – from A to Z
A Cancer AGES us but isn’t aging what we long for?! B It BLINDS us to far away, future concerns. It brings us to…
Martha Ann Auble Alderman
Martha Ann Auble Alderman passed away peacefully in her sleep on Wednesday, July 31 after a brief, but hard-fought battle…
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Study Name Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene ClinicalTrials.gov Identifier…
A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients with Locally Advanced, Recurrent, or Metastatic Biliary Tract Cancers
Study Name • A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating…
Olga Mech
It is with profound sadness that the family announce the passing of Olga, lifelong beloved wife, mother and grandmother and…
A Phase 3, First Line Study of Pemigatinib vs Gemcitabine/Cisplatin in Patients with Cholangiocarcinoma
Study Name A Phase 3, First Line Study of Pemigatinib vs Gemcitabine/Cisplatin in Patients with Cholangiocarcinoma ClinicalTrials.gov Identifier (if applicable)…
Helping Bile Duct Cancer Patients Find Specialists Nationwide
Read the full article by clicking here.
2019 Annual Conference Videos
All of the presentations at our 2019 Annual Conference are online and waiting to be viewed! Visit our Conference in Review page…